Please login to the form below

Not currently logged in
Email:
Password:

Jounce Therapeutics

This page shows the latest Jounce Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Jounce bags $225m upfront in Celgene immuno-oncology deal

Jounce bags $225m upfront in Celgene immuno-oncology deal

Celgene has bolstered its immuno-oncology pipeline in an agreement with US biotech Jounce Therapeutics that gives it options on five experimental cancer therapies. ... According to Jounce Celgene was one of several companies trying to close a licensing

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch July 2016 Deal Watch July 2016

    $240m. Bayer. X-Chem. $528m. N/A. Topping the charts this month is the $2.6bn strategic collaboration deal that Celgene signed with Jounce Therapeutics for its platform and portfolio of ... Jounce Therapeutics/ Celgene. Portfolio and platform of

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re an independent brand and marketing agency that believes our DNA is a little different from others. * A respectful,...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics